Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Assistance Publique - Hôpitaux de Paris Institut National de la Santé Et de la Recherche Médicale, France International Atomic Energy Agency |
---|---|
Information provided by: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT00190216 |
The hypothesis of this study was that transcranial magnetic stimulation (TMS) focused on hyperfunctional cerebral areas should be more effective in treating depressive symptoms than stimulations not taking into account the functional specificity of the patient. The goal was to compare the effects of "guided" TMS, using neuroimaging to guide TMS on dysfunctional cortical regions individually detected by neuroimaging, with "standard TMS", as used in most studies, over the left prefrontal cortex, and with sham TMS, in patients with resistant depression.
Condition | Intervention | Phase |
---|---|---|
Depression |
Device: Magnetic stimulator |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Caregiver, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression |
Enrollment: | 60 |
Study Start Date: | December 2001 |
Study Completion Date: | October 2007 |
Arms | Assigned Interventions |
---|---|
A: Experimental | Device: Magnetic stimulator |
The objectives of the study were :
Depressed patients meeting DSM-IV criteria for Major Depressive Disorder, aged between 18 and 55, have been included. They met criteria for depression resistant to antidepressant drugs They were randomised in 3 groups: guided prefrontal TMS, standard left prefrontal and sham left prefrontal TMS.
rTMS was administered daily on working days, for two weeks. Ten stimuli per second (10Hz) were applied in 20 courses so that patients received 1600 stimuli per day. Guided TMS was on a prefrontal target corresponding to the highest statistically significant hyperfunctional cluster determined with rCMRGlu PET. Standard stimulation was left pre-frontal, 5 cm anterior to the optimal stimulation point of the abductor pollices brevis. Stimulation strength was chosen at 90% relative to motor threshold. Sham rTMS used a procedure identical to the real standard treatment, but using a sham coil.
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
Albert Chenevier Hospital, Department of psychiatry | |
CRETEIL, France, 94000 |
Principal Investigator: | Marie-Laure PAILLERE MARTINOT, MD; PhD | Assistance Publique - Hôpitaux de Paris |
Study ID Numbers: | AOM98099, P000606 |
Study First Received: | September 13, 2005 |
Last Updated: | November 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00190216 History of Changes |
Health Authority: | France: Ministry of Health |
Resistant depression Transcranial Magnetic Stimulation, Neuroimaging |
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |